se of sedating antidepressant to reduce the benzodiazepine use in patients with depressio
Not Applicable
Completed
- Conditions
- Health Condition 1: F325- Major depressive disorder, singleepisode, in full remission
- Registration Number
- CTRI/2022/08/044959
- Lead Sponsor
- Drashti Manishbhai Shah
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Patients known case of MDD in remission for 3 months or more
2. Currently no history of alcohol use in last 3 months
Exclusion Criteria
Patients with other disorders than MDD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method